Creators of Cycloset®*, the first and only FDA approved sympatholytic dopamine D2 receptor agonist for the treatment of type 2 diabetes.
*See full prescribing info
- Pipeline
- Cycloset for Pediatric T2DM Patients
- VS41157 for Pancreatic Cancer
- Visit www.cycloset.com for
more information on the product

